Concepedia

Author

Michael Shechter

Sheba Medical CenterORCID

Also Known As

A. Bashkin, Amit Segev, Karl Andersen, M D Shechter, M SHECHTER, M Shechter, M. Shechter, MICHAEL SHECHTER, Michael Shechter, Shaul Atar

166

Publications

18.8K

Citations

37

H-Index

78

Concepts

All Affiliations

Sheba Medical CenterTel Aviv UniversityCedars-Sinai Medical Center
MS

About

Michael Shechter is an author at Sheba Medical Center specializing in medicine, cardiology, and cardiovascular disease.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

26

41

2.7K

2

Public Health

11

11

587

3

Health Sciences

10

10

362

4

Applied Physiology

5

5

139

5

Biochemistry

1

1

69

Michael Shechter

×

60

Publications

4.9K

Citations

31

H-Index

YearCitations

Clopidogrel Resistance Is Associated With Increased Risk of Recurrent Atherothrombotic Events in Patients With Acute Myocardial Infarction

Shlomi Matetzky, Victor Guetta, Michael Shechter,

Circulation

2004

1.4K

Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial

Piotr Ponikowski, Bridget‐Anne Kirwan, Stefan D. Anker,

The Lancet

2020

723

Oral Magnesium Therapy Improves Endothelial Function in Patients With Coronary Artery Disease

Michael Shechter, Michael Sharir, Maura J. Paul Labrador,

Circulation

2000

288

Long-term association of brachial artery flow-mediated vasodilation and cardiovascular events in middle-aged subjects with no apparent heart disease

Michael Shechter, Assaf Issachar, Ibrahim Marai,

International Journal of Cardiology

2008

229

Usefulness of Brachial Artery Flow-Mediated Dilation to Predict Long-Term Cardiovascular Events in Subjects Without Heart Disease

Michael Shechter, Alon Shechter, Nira Koren‐Morag,

The American Journal of Cardiology

2013

156

Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial

Giora Weisz, Philippe Généreux, Andrés Íñiguez,

The Lancet

2015

115

Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

Emil Hagström, Philippe Gabríel Steg, Michael Szarek,

Circulation

2022

112

Oral magnesium supplementation inhibits platelet-dependent thrombosis in patients with coronary artery disease

Michael Shechter, C. Noel Bairey Merz, Maura Paul‐Labrador,

The American Journal of Cardiology

1999

110

Vascular Endothelial Function Predicts Mortality Risk in Patients with Advanced Ischaemic Chronic Heart Failure

Michael Shechter, Shlomi Matetzky, Michael Arad,

European Journal of Heart Failure

2009

106

Beneficial effect of magnesium sulfate in acute myocardial infarction

Michael Shechter, Hanoch Hod, Nila Marks,

The American Journal of Cardiology

1990

105

Page 1